ALSAF logo

Safe Orthopaedics SA Stock Price

ENXTPA:ALSAF Community·€127.5k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

ALSAF Share Price Performance

€0.64
-1.76 (-73.33%)
€0.64
-1.76 (-73.33%)
Price €0.64

ALSAF Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk and slightly overvalued.

6 Risks
0 Rewards

Safe Orthopaedics SA Key Details

€5.4m

Revenue

€1.8m

Cost of Revenue

€3.6m

Gross Profit

€8.2m

Other Expenses

-€4.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-23.46
66.24%
-87.14%
-119.3%
View Full Analysis

About ALSAF

Founded
2010
Employees
87
CEO
Nicolas Papillon
WebsiteView website
www.safeorthopaedics.com

Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Fleurieux-sur-l'Arbresle, France.

Recent ALSAF News & Updates

Recent updates

No updates